Clinical Trial Detail

NCT ID NCT03127735
Title BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender
Phase Phase I
Variant Requirements Yes
Sponsors Bayer
Indications

acute myeloid leukemia

Therapies

BAY1436032

Age Groups: senior adult

Additional content available in CKB BOOST